Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.
about
Lead and mercury exposures: interpretation and actionACMT position statement: the Iom report on thimerosal and autismWhen science is not enough - a risk/benefit profile of thiomersal-containing vaccinesAbnormal Brain Connectivity Spectrum Disorders Following Thimerosal Administration: A Prospective Longitudinal Case-Control Assessment of Medical Records in the Vaccine Safety Datalink.A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disordersMitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to thimerosal and other metal compoundsThimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink.Thimerosal exposure and the role of sulfation chemistry and thiol availability in autism.Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins.Managing a child with possible allergy to vaccine.Thimerosal exposure and disturbance of emotions specific to childhood and adolescence: A case-control study in the Vaccine Safety Datalink (VSD) database.Incorporating ethnographic methods in multidisciplinary approaches to risk assessment and communication: cultural and religious uses of mercury in Latino and Caribbean communities.A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services.
P2860
Q22306045-4DA8AD74-451F-4F95-865B-0B4FFAC26641Q28260620-FADB3668-93A2-457A-B085-CFBF26FCD523Q28288152-D9562435-219C-48C0-A5D1-332BBB55BC06Q33693281-2B5BC179-8BD4-47AF-ABB9-5A2ACE663816Q34348131-EBD3245A-F8BE-4481-AE26-B335ED3168DEQ35095201-0EFCA748-AC0C-43B6-A852-2C2DC5CED8EAQ37170244-59DAD2E4-C677-4094-9EA1-8DF8DD8CAC50Q37175425-EB5F80F3-9B43-4275-80A4-F62D928B7556Q37503349-109CF5CE-467D-4427-99D8-E0C447CE784FQ38153078-83E92803-9AE8-483C-A795-5857394BAA0BQ39012771-2B39EDCE-7E7E-431E-BAFE-F2300EE19546Q40277295-3C8FB375-7076-49B5-A317-F06FCADF518EQ47735290-0697F631-216F-486E-8042-1ADD8EACB60E
P2860
Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Thiomersal in vaccines: balanc ...... f vaccine-preventable disease.
@ast
Thiomersal in vaccines: balanc ...... f vaccine-preventable disease.
@en
type
label
Thiomersal in vaccines: balanc ...... f vaccine-preventable disease.
@ast
Thiomersal in vaccines: balanc ...... f vaccine-preventable disease.
@en
prefLabel
Thiomersal in vaccines: balanc ...... f vaccine-preventable disease.
@ast
Thiomersal in vaccines: balanc ...... f vaccine-preventable disease.
@en
P1433
P1476
Thiomersal in vaccines: balanc ...... f vaccine-preventable disease.
@en
P2093
Mark Bigham
P304
P356
10.2165/00002018-200528020-00001
P577
2005-01-01T00:00:00Z
P6179
1044386431